LA County has the largest incident population of HIV positive individuals in the United States.
One of the most widely advocated strategies for dealing with HIV/AIDS could double the number of multi-drug-resistant HIV cases in the population of men who have sex with men (MSM) in LA County over the next 10 years, cautions a new study.
To Beat Tropical Diseases, Immune Finding Aids Quest For Vaccines
For a range of diseases that affect 200 million people, mainly in tropical south-east Asia, Africa and Central America, scientists are a step closer to developing vaccines.
Advertisement
The so-called "test and treat" policy — which calls for universal testing for HIV as well as treatment with antiretroviral drugs for even those at the earliest stages of the disease — is popular because it has been shown to decrease the number of new HIV cases and deaths due to AIDS.
The problem, according to the study, is that such aggressive and widespread use of antiretroviral drugs would also rapidly and dramatically increase the prevalence of multiple-drug-resistant HIV (MDR).
![Religious Taboos Dampen AIDS Tests in Morocco]( "Religious Taboos Dampen AIDS Tests in Morocco")
Women in Morocco turn towards mobile clinics offering free AIDS tests as they 'don't have anything'
"We're not saying that testing everybody and treating everybody is bad. All we're saying is that you should proceed with caution and closely monitor the prevalence of multi-drug-resistant HIV as you scale up the test and treat model," said lead author Neeraj Sood, associate professor at the USC Schaeffer Center for Health Policy and Economics.
Sood collaborated with Zachary Wagner, also of the USC Schaeffer Center; USC Ph.D. student Emmanuel Drabo; and Raffaele Vardavas and Amber Jaycocks of the RAND Corporation. Their study received advance online publication by Clinical Infectious Diseases on March 13.
Sood and his colleagues studied the MSM population in LA County, which accounts for 82 percent of people living with HIV/AIDS countywide. They tracked how the disease was treated from 2000 to 2009 and how the virus responded.
Using data from the Centers for Disease Control and their own data, the researchers then generated a model of how the disease would respond under a more aggressive "test and treat" policy over the next 10 years.
The model showed the prevalence of MDR jumping from 4.79 percent to 9.06 percent by 2023.
A more cautious approach, Sood suggested, would be simply to aggressively test for the disease but to avoid prescribing antiretroviral drugs to asymptomatic patients. The modeling shows that strategy still making significant gains against HIV/AIDS, without the increase in MDR HIV.
"Prior studies show a dramatic reduction in risk-taking behavior by individuals once they know their HIV-positive status," Sood said.
Source: Eurekalert
Religious Taboos Dampen AIDS Tests in Morocco
Women in Morocco turn towards mobile clinics offering free AIDS tests as they 'don't have anything'
Advertisement
"We're not saying that testing everybody and treating everybody is bad. All we're saying is that you should proceed with caution and closely monitor the prevalence of multi-drug-resistant HIV as you scale up the test and treat model," said lead author Neeraj Sood, associate professor at the USC Schaeffer Center for Health Policy and Economics.
Sood collaborated with Zachary Wagner, also of the USC Schaeffer Center; USC Ph.D. student Emmanuel Drabo; and Raffaele Vardavas and Amber Jaycocks of the RAND Corporation. Their study received advance online publication by Clinical Infectious Diseases on March 13.
Sood and his colleagues studied the MSM population in LA County, which accounts for 82 percent of people living with HIV/AIDS countywide. They tracked how the disease was treated from 2000 to 2009 and how the virus responded.
Using data from the Centers for Disease Control and their own data, the researchers then generated a model of how the disease would respond under a more aggressive "test and treat" policy over the next 10 years.
The model showed the prevalence of MDR jumping from 4.79 percent to 9.06 percent by 2023.
A more cautious approach, Sood suggested, would be simply to aggressively test for the disease but to avoid prescribing antiretroviral drugs to asymptomatic patients. The modeling shows that strategy still making significant gains against HIV/AIDS, without the increase in MDR HIV.
"Prior studies show a dramatic reduction in risk-taking behavior by individuals once they know their HIV-positive status," Sood said.
Source: Eurekalert
High Levels of Antibacterial Protein in Genetically Modified Goat’s Milk Aids Diarrhea Treatment
Genetically modified goat's milk contains increased amounts of antibacterial protein and this could be used to treat diarrhea in children, reports a recent study.
Advertisement
 Major Breakthrough Aids In Diagnosing Alzheimer's 15 Years Before Symptoms StrikeA major breakthrough was made by researchers from Melbourne in diagnosing Alzheimer's 15 years before symptoms strike, offering hope of avoiding dementia. | Advertisement
|
Advertisement
Recommended Readings
Latest Research News
Cerebrospinal fluid (CSF) leaks are detected in approximately 1-3% of adults who have experienced a traumatic brain injury.
The optogenetic activation of hippocampal astrocytes can be viewed as a novel therapeutic avenue for addressing Alzheimer's disease.
In Alzheimer's disease condition, the control and adjustment of ABCA7 levels in response to inflammation and the decrease in the availability of cholesterol.
Atopic dermatitis (AD) and inflammatory bowel disease (IBD) can lead to alterations in the microbiome, and disruptions in the skin and gut barrier.
Gaining insights into mortality risks among vitiligo patients will enhance patient counseling, healthcare monitoring, and overall patient management strategies.
